In previous studies we reported that ADF glioblastoma cells carried an endogenous wild-type p53 whose transcriptional activity could not be activated by chemotherapeutic agent such as ADR, although the molecular mechanisms of such inhibition are still elusive (19,20). Here, TP53 is linked to glioblastoma.